Sigyn Therapeutics (SIGY) Operating Expenses (2017 - 2025)
Sigyn Therapeutics (SIGY) posted Operating Expenses of $386529.0 for Q3 2025, down 17.67% sequentially from $469513.0 in Q2 2025, and down 52.19% YoY from $808458.0 in Q3 2024.
Sigyn Therapeutics (SIGY) Operating Expenses (2017 - 2025) Analysis & Trends
Sigyn Therapeutics has reported Operating Expenses for 9 years, with the latest figure at $386529.0 in Q3 2025.
- Quarterly Operating Expenses fell 52.19% year-over-year to $386529.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.9 million (down 31.84% YoY) and the FY2024 annual result came in at $2.5 million, up 2.6% from the prior year.
- Operating Expenses declined to $386529.0 in Q3 2025 per SIGY's latest filing, from $469513.0 in the prior quarter.
- Over five years, Operating Expenses peaked at $808458.0 in Q3 2024 and troughed at $386529.0 in Q3 2025.
- A 5-year average of $554323.4 and a median of $546059.0 in 2025 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2021 and 2025: Operating Expenses soared 182.48% in 2021, then slumped 52.19% in 2025.
- Over 5 years, Operating Expenses stood at $590939.0 in 2021, then declined by 20.2% to $471588.0 in 2022, then soared by 52.09% to $717236.0 in 2023, then sank by 33.35% to $478010.0 in 2024, then declined by 19.14% to $386529.0 in 2025.
- According to Business Quant data, Operating Expenses over the past three periods registered $386529.0, $469513.0, and $546059.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | 386,529.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 386,529.00 |
| Jun 30, 2025 | 469,513.00 |
| Mar 31, 2025 | 546,059.00 |
| Dec 31, 2024 | 478,010.00 |
| Sep 30, 2024 | 808,458.00 |
| Jun 30, 2024 | 602,805.00 |
| Mar 31, 2024 | 629,972.00 |
| Dec 31, 2023 | 717,236.00 |
| Sep 30, 2023 | 642,814.00 |
| Jun 30, 2023 | 574,009.00 |
| Mar 31, 2023 | 521,258.00 |
| Dec 31, 2022 | 471,588.00 |
| Sep 30, 2022 | 533,647.00 |
| Jun 30, 2022 | 532,795.00 |
| Mar 31, 2022 | 609,236.00 |
| Dec 31, 2021 | 590,939.00 |
| Sep 30, 2021 | 573,363.00 |
| Jun 30, 2021 | 441,818.00 |
| Mar 31, 2021 | 402,096.00 |
| Dec 31, 2020 | 344,567.00 |